Detailed answers about INTEGRAL CATARACT AND RETINAL SURGERY LIMITED, including incorporation, status, business activity, and accounts information.
When was INTEGRAL CATARACT AND RETINAL SURGERY LIMITED founded?
INTEGRAL CATARACT AND RETINAL SURGERY LIMITED was officially incorporated on 2 March 2026 and is registered under company number 17062252. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTEGRAL CATARACT AND RETINAL SURGERY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INTEGRAL CATARACT AND RETINAL SURGERY LIMITED?
INTEGRAL CATARACT AND RETINAL SURGERY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTEGRAL CATARACT AND RETINAL SURGERY LIMITED do?
INTEGRAL CATARACT AND RETINAL SURGERY LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is INTEGRAL CATARACT AND RETINAL SURGERY LIMITED's registered address?
The registered office address of INTEGRAL CATARACT AND RETINAL SURGERY LIMITED is 4 Ynys Bridge Court, Gwaelod Y Garth, Cardiff, United Kingdom, CF15 9SS. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTEGRAL CATARACT AND RETINAL SURGERY LIMITED financially stable?
Financial accounts for INTEGRAL CATARACT AND RETINAL SURGERY LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.